Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

AZD6140 Exerts greater inhibition of platelet aggregation than clopidogrel in patients with stable atherosclerotic disease or unstable coronary disease

AZD6140 Exerts greater inhibition of platelet aggregation than clopidogrel in patients with stable atherosclerotic disease or unstable coronary disease. Circulation. 2006; 114(18):II-698.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.